Schedule 13G ownership disclosure
Aldeyra Therapeutics Inc
Security class unavailable · CUSIP: 01438T106
Event date: 2019-09-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,418,822
- Percent of class
- 5.1400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-19-003845
- Form type
- SC 13G
- Filer
- ADAGE CAPITAL PARTNERS GP, L.L.C.
- CIK
- CIK 1165408
- Filed
- Sep 27, 2019
- Reporting period
- Sep 17, 2019
- Description
- Schedule 13G beneficial ownership